[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Pharmaceuticals Market Research Reports & Industry Analysis

Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.

The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.

The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.

Publications found: 33,057
Sort by:

Vitiligo Drug-South America Market Status and Trend Report 2013-2023

US$ 3,480.00

Report Vitiligo Drug-South America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Vitiligo Drug industry, standing on the readers? perspective, delivering detailed marke...

March 2018 146 pages

Vitiligo Drug-United States Market Status and Trend Report 2013-2023

US$ 3,480.00

Report Vitiligo Drug-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Vitiligo Drug industry, standing on the readers? perspective, delivering detailed marke...

March 2018 144 pages

X-protein-Asia Pacific Market Status and Trend Report 2013-2023

US$ 3,480.00

Report X-protein-Asia Pacific Market Status and Trend Report 2013-2023 offers a comprehensive analysis on X-protein industry, standing on the readers? perspective, delivering detailed market data an...

March 2018 147 pages

X-protein-China Market Status and Trend Report 2013-2023

US$ 2,980.00

Report X-protein-China Market Status and Trend Report 2013-2023 offers a comprehensive analysis on X-protein industry, standing on the readers? perspective, delivering detailed market data and penet...

March 2018 153 pages

X-protein-EMEA Market Status and Trend Report 2013-2023

US$ 3,480.00

Report X-protein-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on X-protein industry, standing on the readers? perspective, delivering detailed market data and penetr...

March 2018 156 pages

X-protein-Europe Market Status and Trend Report 2013-2023

US$ 3,480.00

Report X-protein-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on X-protein industry, standing on the readers? perspective, delivering detailed market data and pene...

March 2018 156 pages

X-protein-Global Market Status and Trend Report 2013-2023

US$ 2,480.00

Report X-protein-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on X-protein industry, standing on the readers? perspective, delivering detailed market data and pene...

March 2018 143 pages

X-protein-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data

US$ 3,680.00

Report X-protein-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on X-protein industry, standing on the readers? perspective, delivering detailed...

March 2018 146 pages

X-protein-India Market Status and Trend Report 2013-2023

US$ 2,980.00

Report X-protein-India Market Status and Trend Report 2013-2023 offers a comprehensive analysis on X-protein industry, standing on the readers? perspective, delivering detailed market data and penet...

March 2018 153 pages

X-protein-North America Market Status and Trend Report 2013-2023

US$ 3,480.00

Report X-protein-North America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on X-protein industry, standing on the readers? perspective, delivering detailed market data a...

March 2018 133 pages

X-protein-South America Market Status and Trend Report 2013-2023

US$ 3,480.00

Report X-protein-South America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on X-protein industry, standing on the readers? perspective, delivering detailed market data a...

March 2018 136 pages

X-protein-United States Market Status and Trend Report 2013-2023

US$ 3,480.00

Report X-protein-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on X-protein industry, standing on the readers? perspective, delivering detailed market data a...

March 2018 147 pages

Zika Virus Vaccines-Asia Pacific Market Status and Trend Report 2013-2023

US$ 3,480.00

Report Zika Virus Vaccines-Asia Pacific Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Zika Virus Vaccines industry, standing on the readers? perspective, delivering det...

March 2018 130 pages

Zika Virus Vaccines-China Market Status and Trend Report 2013-2023

US$ 2,980.00

Report Zika Virus Vaccines-China Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Zika Virus Vaccines industry, standing on the readers? perspective, delivering detailed m...

March 2018 145 pages

Zika Virus Vaccines-EMEA Market Status and Trend Report 2013-2023

US$ 3,480.00

Report Zika Virus Vaccines-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Zika Virus Vaccines industry, standing on the readers? perspective, delivering detailed ma...

March 2018 142 pages

Zika Virus Vaccines-Europe Market Status and Trend Report 2013-2023

US$ 3,480.00

Report Zika Virus Vaccines-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Zika Virus Vaccines industry, standing on the readers? perspective, delivering detailed...

March 2018 140 pages

Zika Virus Vaccines-Global Market Status and Trend Report 2013-2023

US$ 2,480.00

Report Zika Virus Vaccines-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Zika Virus Vaccines industry, standing on the readers? perspective, delivering detailed...

March 2018 137 pages

Zika Virus Vaccines-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data

US$ 3,680.00

Report Zika Virus Vaccines-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Zika Virus Vaccines industry, standing on the readers? perspective,...

March 2018 156 pages

Zika Virus Vaccines-India Market Status and Trend Report 2013-2023

US$ 2,980.00

Report Zika Virus Vaccines-India Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Zika Virus Vaccines industry, standing on the readers? perspective, delivering detailed m...

March 2018 131 pages

Zika Virus Vaccines-North America Market Status and Trend Report 2013-2023

US$ 3,480.00

Report Zika Virus Vaccines-North America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Zika Virus Vaccines industry, standing on the readers? perspective, delivering de...

March 2018 131 pages

Zika Virus Vaccines-South America Market Status and Trend Report 2013-2023

US$ 3,480.00

Report Zika Virus Vaccines-South America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Zika Virus Vaccines industry, standing on the readers? perspective, delivering de...

March 2018 145 pages

Zika Virus Vaccines-United States Market Status and Trend Report 2013-2023

US$ 3,480.00

Report Zika Virus Vaccines-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Zika Virus Vaccines industry, standing on the readers? perspective, delivering de...

March 2018 150 pages

Global Vitamin B & C Ingredients Market Report 2018

US$ 2,350.00

... $ in 2017, BisReport analysts believe that in the next few years, Vitamin B & C Ingredients market size will be further expanded, we expect ... Africa, GCC) Section (5 6 7): 500 USD- Product Type Segmentation (Vitamin C, Vitamin B) Industry Segmentation (Pharmaceuticals, Food & Beverages, Cosmetics, Animal Feeds, ...

March 2018 120 pages

Benchmarking Pharma’s MSL Capabilities

US$ 2,495.00

... included in Benchmarking Pharma's MSL Capabilities The need for on-demand MSLs is rising; ... Benchmarking Pharma's MSL Capabilities Mark Rees-Saunders, Medical Affairs Excellence Lead, AstraZeneca UK Senior MSL Manager, Top 10 Pharma Company, UK MSL Director, Specialty Pharma Company, UK Carmen Sanchez Puyol, MSL ...

March 2018

Drugs of Abuse Testing - Global Market Outlook (2017-2026)

US$ 4,150.00

... the use of illegal drugs. The drug of abuse testing can be performed for a variety of reasons such as Employment drug testing, medical screening, athletics testing, and legal forensic information ...

March 2018 148 pages

Global Parkinson’s Disease Treatment Market(By Product- Carbidopa/Levodopa, Dopamine Receptor Agonists, Mao Inhibitors, Comt Inhibitors, Anticholinergics, and Other Drugs, By Channel Of Distribution- Hospitals, Healthcare Institutes and Others, By Geography- North America, Europe, Asia-Pacific, Middle-East and Africa and Latin America)

US$ 4,795.00

... global market. The global Parkinson’s disease treatment market has been segmented into: Global Parkinson’s Disease Treatment Market: By Product Carbidopa/levodopa, Dopamine Receptor Agonists, MAO inhibitors COMT inhibitors, Anticholinergics, Other drugs Global Parkinson’s Disease Treatment Market ...

March 2018 148 pages

Asia-Pacific Injectable Drug Delivery Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

US$ 2,500.00

... report. The Asia-Pacific injectable drug delivery market is segmented based on type into two notable segments; injectable drug delivery device and injectable drug delivery formulation. Injectable drug delivery device market is segmented into conventional injection devices and ...

March 2018 388 pages

Europe Injectable Drug Delivery Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

US$ 2,500.00

... report. The Europe injectable drug delivery market is segmented based on type into two notable segments; injectable drug delivery device and injectable drug delivery formulation. Injectable drug delivery device market is segmented into conventional injection devices and ...

March 2018 394 pages

Global Injectable Drug Delivery Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

US$ 4,200.00

... report. The global injectable drug delivery market is segmented based on type into two notable segments; injectable drug delivery device and injectable drug delivery formulation. Injectable drug delivery device market is segmented into conventional injection devices and ...

March 2018 741 pages

North America Injectable Drug Delivery Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

US$ 2,500.00

... Distribution Channel Application Geography The North America injectable drug delivery market is segmented on of ... North America injectable drug delivery market is segmented based on type into two notable segments; injectable drug delivery device and injectable drug delivery formulation. Injectable drug delivery ...

March 2018 269 pages

Global Cephalosporin Drugs Industry Market Research 2018

US$ 2,600.00

... of the Cephalosporin Drugs market? 9. What are the Cephalosporin Drugs market challenges to market growth? 10. What are the Cephalosporin Drugs market opportunities and threats faced by the vendors in the global Cephalosporin Drugs market? Objective of Studies ...

March 2018 148 pages

Global Oncology Drugs Market 2018-2024

US$ 2,750.00

... for the manufacturers of cancer drugs. Market Analysis: The global oncology drugs market is estimated to witness a CAGR of 7.0% during the forecast period 2018–2024. The market is analyzed based on three segments ...

March 2018 102 pages

Global Respiratory Drugs Market 2018-2024

US$ 2,750.00

... underlying causes, ranging from inherited mutations to pathological inflammation. The respiratory disorders market is dominated by long-acting beta-agonist (LABA) and ... and asthma. These drugs stimulate muscles surrounding the bronchial tubes to suppress and open the airways. Respiratory therapy area consists ...

March 2018 113 pages

Global Brucella Abortus Vaccines Industry Market Research 2018

US$ 2,600.00

... are the Brucella Abortus Vaccines market challenges to market growth? 10. What are the Brucella Abortus Vaccines market opportunities and threats faced by the vendors in the global Brucella Abortus Vaccines market ...

March 2018 154 pages

Cathepsin L1 (Cathepsin L or Major Excreted Protein or CTSL or EC 3.4.22.15) - Pipeline Review, H1 2018

US$ 3,500.00

... Cathepsin L1 (Cathepsin L or Major Excreted Protein or CTSL or EC 3.4.22.15) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

March 2018 28 pages

Cathepsin S (CTSS or EC 3.4.22.27) - Pipeline Review, H1 2018

US$ 3,500.00

... and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Cathepsin S (CTSS or EC 3.4.22.27) development landscape Develop and design in-licensing and ...

March 2018 31 pages

Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC 3.4.21.27) - Pipeline Review, H1 2018

US$ 3,500.00

... Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC 3.4.21.27) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

March 2018 57 pages

Gamma Secretase (EC 3.4.23.) - Pipeline Review, H1 2018

US$ 3,500.00

... and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Gamma Secretase (EC 3.4.23.) development landscape Develop and design in-licensing and ...

March 2018 53 pages

Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 (GABA(A) Receptor Subunit Gamma 2 or GABRG2) - Pipeline Review, H1 2018

US$ 3,500.00

... Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 (GABA(A) Receptor Subunit Gamma 2 or GABRG2) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

March 2018 50 pages

Human cytomegalovirus 65 kDa Phosphoprotein (PP65 or 65 kDa Matrix Phosphoprotein or Tegument Protein UL83 or UL83) - Pipeline Review, H1 2018

US$ 3,500.00

... effectively by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Human cytomegalovirus 65 kDa Phosphoprotein (PP65 or 65 kDa Matrix Phosphoprotein or Tegument Protein UL83 or UL83) development landscape Develop and design ...

March 2018 48 pages

Human Parainfluenza Virus 3 Infections - Pipeline Review, H1 2018

US$ 2,000.00

... . The Human Parainfluenza Virus 3 Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Human Parainfluenza Virus 3 Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

March 2018 32 pages

Matrix Metalloproteinase 9 (Gelatinase B or 92 kDa Type IV Collagenase or 92 kDa Gelatinase or MMP9 or EC 3.4.24.35) - Pipeline Review, H1 2018

US$ 3,500.00

... effectively by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Matrix Metalloproteinase 9 (Gelatinase B or 92 kDa Type IV Collagenase or 92 kDa Gelatinase or MMP9 or EC 3.4.24.35) development landscape Develop and design ...

March 2018 52 pages

Methionine Aminopeptidase 2 (Initiation Factor 2 Associated 67 kDa Glycoprotein or Peptidase M 2 or eIF 2 Associated p67 Homolog or METAP2 or EC 3.4.11.18) - Pipeline Review, H1 2018

US$ 3,500.00

... key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Methionine Aminopeptidase 2 (Initiation Factor 2 Associated 67 kDa Glycoprotein or Peptidase M 2 or eIF 2 Associated p67 Homolog or METAP2 or EC 3.4.11.18) development landscape Develop ...

March 2018 62 pages

Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) - Pipeline Review, H1 2018

US$ 3,500.00

... Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

March 2018 73 pages

Tyrosine Protein Phosphatase Non Receptor Type 1 (Protein Tyrosine Phosphatase 1B or Protein Tyrosine Phosphatase Placental or PTP1B or PTPN1 or EC 3.1.3.48) - Pipeline Review, H1 2018

US$ 3,500.00

... key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Tyrosine Protein Phosphatase Non Receptor Type 1 (Protein Tyrosine Phosphatase 1B or Protein Tyrosine Phosphatase Placental or PTP1B or PTPN1 or EC 3.1.3.48) development landscape ...

March 2018 51 pages

Xerostomia - Pipeline Review, H1 2018

US$ 2,000.00

... and Dental Disorders) pipeline guide also reviews of key players involved in therapeutic development for Xerostomia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

March 2018 41 pages

Drugs for Urinary Incontinence and Overactive Bladder: Global Markets to 2022

US$ 1,375.00

... urinary incontinence and overactive bladder by type. Product type include Idiopathic Bladder Overactivity, and Neurogenic Bladder Overactivity. Report Includes: 96 data tables. An overview of the global market for drugs for urinary incontinence and overactive bladder Analyses of global market ...

March 2018 179 pages

Vaccine Market in Australia to 2022

US$ 603.13

... future outlook of the vaccine market in Australia to 2022 Track industry developments and identify market opportunities Plan and develop marketing, market-entry, market expansion, and other business ...

March 2018 13 pages

Vaccine Market in Austria to 2022

US$ 603.13

... size of the vaccine market in Austria? How is the market split into different types of vaccines? How are the overall market and different product ... of the vaccine market in Austria to 2022 Track industry developments and identify market opportunities Plan and develop marketing, market-entry, market expansion, ...

March 2018 13 pages

Filters

Search

Categories

23,521
914
8,559
40
23

Publishers

72
1
6
4
18
50
16
3
112
292
33
30
34
6,128
163
13
120
12
142
51
363
8
25
84
36
7
8
14
6
49
113
7
1
1,818
10
579
11
2,786
7
24
5,307
44
31
54
216
1,098
40
32
7
37
46
43
50
2,538
208
40
26
7
6
2
4
32
15
606
3,346
2,222
11
22
1
16
38
228
2
7
10
4
79
4
26
50
1
5
6
2
2
32
2
13
17
1
11
107
36
1
18
195
172
6
4
2
1
5
4
9
1
72
12
27
50
33
1
27
27
1
2
1
42
55
14
18
1
323
954
555
2
1
2
5
88
72
59
37
41
22
2
14
5
23
2
2

Regions

14
13
12
11
8
7
6
3
3
2
2
1
4
7
19
8
1,367
101
83
57
51
50
48
34
28
27
26
25
25
22
22
21
20
19
19
19
19
19
19
19
19
18
18
18
18
17
17
16
16
16
16
16
16
16
16
15
15
14
13
13
12
12
11
11
11
11
11
10
10
8
7
5
1,703
741
22
20
14
1,325
701
597
31
30
7
6
6
5
5
4
5
5
5
4
3
1
1
1
1
25
4
11
2
2
2
2
693
7
13
10
6
46
12
6
57
4
24,205

Price

Date

Pages

Offers

16
16
10
44
5
1
2